This is a very easy call--
BFNH.OB...I have been pointing out from time to time last few days or week that once investors figure out that making a bet on a stock in the drug/biotech sector of stem cells will eventually do or die as that company's stem cell research does or does not.

But buying a stock that ALL the stem cell research companies can use...and are already using....means that you can play the whole niche buy buying a stock that is part of the toolbox necessary to do the research in the first place---exactly what you have right here in this PR just out from BFNH.

At this price it is a huge gift. The rules just changed today and BFNH will be recognized now for more than just their nanotechnology---which they have in spades. You now have nanotechnology ties into stem cell research---that is a powerful combination for only. 14 per share cost with 25m shares out.....this just out--

BioForce Nanosciences Applauds Research Stimulus and Reversal of
Ban on Stem Cell Funding
BioForce Nanosciences Applauds Research Stimulus and Reversal of Ban on Stem Cel
l Funding

BioForce and Its Customers to Directly Benefit From Federal Policy Changes